CYTOKINE REGULATION OF EOSINOPHIL FUNCTION

被引:75
作者
WELLER, PF
机构
[1] Division of Infectious Diseases, Department of Medicine, Beth Israel Hospital, Boston
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1992年 / 62卷 / 01期
关键词
D O I
10.1016/0090-1229(92)90041-L
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development and function of eosinophils are regulated by a number of cytokines. Three cytokines have major effects on eosinophilopoiesis. Both granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 stimulate the development of eosinophils as well as other leukocytes. Interleukin-5 promotes eosinophil development and terminal differentiation. These three cytokines also effect the functions of mature eosinophils and can prolong their longevity in in vitro culture, enhance their capacity for release of leukotriene C4 (LTC4), augment their capacity for helminthotoxicity and degranulation, and render them less dense ("hypodense") than normal, unactivated eosinophils. GM-CSF can also induce the expression of HLA-DR on mature eosinophils, which can enable eosinophils to serve as antigen-presenting cells in stimulating T-cell responses. A T-cell-derived cytokine, lymphocyte chemoattractant factor (LCF), which stimulates the migration and function of CD4+ lymphocytes and eosinophils, also utilizes CD4 expressed on human eosinophils as its receptor. LCF stimulates eosinophil migration but not degranulation, leukotriene C4 release, or respiratory burst activity. Interleukin-2 is also a potent chemoattractant for eosinophils. Thus, cytokines are involved in both increased production of eosinophils as well as regulation of the functions of mature eosinophils. These functions of mature eosinophils include effector functions and collaborative interactions with lymphocytes and other tissue cellular elements. © 1992.
引用
收藏
页码:S55 / S59
页数:5
相关论文
共 55 条
[1]   COMPARISON OF HUMAN EOSINOPHILS FROM NORMALS AND PATIENTS WITH EOSINOPHILIA [J].
BASS, DA ;
GROVER, WH ;
LEWIS, JC ;
SZEJDA, P ;
DECHATELET, LR ;
MCCALL, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (06) :1265-1273
[2]  
Beeson PB, 1977, EOSINOPHIL
[3]   CHEMOATTRACTANT LYMPHOKINES SPECIFIC FOR THE HELPER INDUCER LYMPHOCYTE-T SUBSET [J].
BERMAN, JS ;
CRUIKSHANK, WW ;
CENTER, DM ;
THEODORE, AC ;
BEER, DJ .
CELLULAR IMMUNOLOGY, 1985, 95 (01) :105-112
[4]   INTERLEUKIN-5 MODIFIES HISTAMINE-RELEASE AND LEUKOTRIENE GENERATION BY HUMAN BASOPHILS IN RESPONSE TO DIVERSE AGONISTS [J].
BISCHOFF, SC ;
BRUNNER, T ;
DEWECK, AL ;
DAHINDEN, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (06) :1577-1582
[5]  
BUTTERWORTH AE, 1984, ADV PARASIT, V23, P143, DOI 10.1016/S0065-308X(08)60287-0
[6]   CHARACTERIZATION OF A RECEPTOR FOR INTERLEUKIN-5 ON HUMAN EOSINOPHILS - VARIABLE EXPRESSION AND INDUCTION BY GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR [J].
CHIHARA, J ;
PLUMAS, J ;
GRUART, V ;
TAVERNIER, J ;
PRIN, L ;
CAPRON, A ;
CAPRON, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (05) :1347-1351
[7]  
CLUTTERBUCK EJ, 1989, BLOOD, V73, P1504
[8]   ANTIBODY TO INTERLEUKIN-5 INHIBITS HELMINTH-INDUCED EOSINOPHILIA IN MICE [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
HUDAK, S ;
JACKSON, J ;
RENNICK, D .
SCIENCE, 1989, 245 (4915) :308-310
[9]  
CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569
[10]  
CRUIKSHANK WW, 1987, J IMMUNOL, V138, P3817